CS
FATE icon

Candriam SCA’s Fate Therapeutics FATE Stock Holding History

Candriam SCA’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-460,436
Closed -$4.65M – 896
2022
Q4 		$4.65M Hold
460,436
– – 0.03% 394
2022
Q3 		$10.3M Buy
460,436
+236,403
+106% +$6.83M 0.07% 262
2022
Q2 		$5.55M Sell
224,033
-19,407
-8% -$535K 0.05% 313
2022
Q1 		$9.44M Sell
243,440
-7,297
-3% -$283K 0.06% 267
2021
Q4 		$14.7M Hold
250,737
– – 0.09% 214
2021
Q3 		$14.9M Hold
250,737
– – 0.1% 217
2021
Q2 		$21.8M Sell
250,737
-19,370
-7% -$1.56M 0.15% 163
2021
Q1 		$23.6M Sell
270,107
-4
-0% -$383 0.2% 132
2020
Q4 		$24.6M Buy
+270,111
New +$16.8M 0.19% 133

Other funds holding FATE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return